Characteristics of patients with neovascular age-related macular degeneration who were lost to follow-up and those of patients who continued follow-up for 2 years after initiating anti-VEGF treatment.

Characteristics of patients with neovascular age-related macular degeneration who were lost to follow-up and those of patients who continued follow-up for 2 years after initiating anti-VEGF treatment.

<p>Characteristics of patients with neovascular age-related macular degeneration who were lost to follow-up and those of patients who continued follow-up for 2 years after initiating anti-VEGF treatment.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Takaaki Sugisawa (13417212) (author)
مؤلفون آخرون:	Fumi Gomi (278082) (author), Yuri Harada (756097) (author), Hiroko Imaizumi (3545441) (author), Shuichiro Aoki (5778473) (author), Akiko Miki (337892) (author), Maya Kishi (15389105) (author), Tomofusa Yamauchi (428670) (author), Daisuke Nagasato (3574904) (author), Yoko Ozawa (418834) (author), Masatoshi Haruta (9532227) (author), Nobuhiro Kato (21526526) (author), Hisashi Matsubara (651891) (author), Tsutomu Yasukawa (6411377) (author), Aki Kato (588812) (author), Hiroto Terasaki (104937) (author), Takao Hirano (13863990) (author), Yasuhiro Iesato (520685) (author), Hiroki Tsujinaka (8783519) (author), Tomoya Murakami (3134658) (author), Yoshinori Mitamura (361411) (author), Makiko Wakuta (14185640) (author), Kazuhiro Kimura (205831) (author), Masahiko Shimura (19832186) (author)
منشور في:	2025
الموضوعات:	Medicine Cell Biology Neuroscience Biotechnology Developmental Biology Cancer Science Policy Infectious Diseases related macular degeneration corrected visual acuity prior treatment history 8 %, 13 2 %, respectively ltfu vary depending xlink "> data poor baseline bcva worse baseline best specific factors associated significantly less likely term ltfu rates vegf treatment combined bcva ), anti time since initiation identify factors associated worse bcva 8 %, xlink "> significantly associated identify time 2 years term ltfu initiated treatment factors contributing early ), whereas ltfu ltfu rate risk factor photodynamic therapy patient characteristics neovascular age january 2017 initiating anti initial visit december 2020 control design 80 years 60 years 3 months 19 pandemic
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Characteristics of patients with neovascular age-related macular degeneration who were lost to follow-up and those of patients who continued follow-up for one year after initiating anti-VEGF treatment.
حسب: Takaaki Sugisawa (13417212)
منشور في: (2025)

Characteristics of patients with neovascular age-related macular degeneration who were lost to follow-up and those of patients who continued follow-up for 3 months after initiating anti-VEGF treatment.
حسب: Takaaki Sugisawa (13417212)
منشور في: (2025)

Patients’ inclusion period for analyzing follow-up status for up to 3 months, 3 months to 1 year, and 1 year to 2 years.
حسب: Takaaki Sugisawa (13417212)
منشور في: (2025)

Multivariable logistic regression analysis of characteristics of age and baseline BCVA associated with loss to follow-up.
حسب: Takaaki Sugisawa (13417212)
منشور في: (2025)

Comparison of the reasons for loss to follow-up at 3 months, 1 year, and 2 years after treatment initiation.
حسب: Takaaki Sugisawa (13417212)
منشور في: (2025)

The distribution of age, baseline BCVA and nAMD subtype for loss to follow-up between 3 months, 1 year, and 2 years after treatment initiation.
حسب: Takaaki Sugisawa (13417212)
منشور في: (2025)

Prevalence of TB lost to follow-up cases in Ghana from 2019-2023.
حسب: David Ngmenbelle (21647429)
منشور في: (2025)

Image 2_Predictors of loss to follow-up among people living with HIV on antiretroviral therapy in a rural health facility using paper-based records.tiff
حسب: Michael Abugah (22099832)
منشور في: (2025)

Image 1_Predictors of loss to follow-up among people living with HIV on antiretroviral therapy in a rural health facility using paper-based records.tiff
حسب: Michael Abugah (22099832)
منشور في: (2025)

Addressing loss to follow-up in antiretroviral adherence
حسب: Mulalo Mukwevho (20794949)
منشور في: (2025)

Association of frailty index with follow up in patients with diabetic retinopathy
حسب: Logan Bearfield (22185766)
منشور في: (2025)

Kaplan–Meier estimates of time to loss to follow-up (LTFU) according to Type of First Attention (Ambulatory/Emergency Department).
حسب: Paulo Ruiz-Grosso (303702)
منشور في: (2025)

Kaplan–Meier estimates of time to loss to follow-up (LTFU) according to Period of First Attention (PRE/POST COVID-19).
حسب: Paulo Ruiz-Grosso (303702)
منشور في: (2025)

Directed acyclic graph (DAG) of hypothesized relationships between patient characteristics and loss to follow-up (LTFU), with Type of First Attention (Ambulatory/Emergency) as the exposure.
حسب: Paulo Ruiz-Grosso (303702)
منشور في: (2025)

Directed acyclic graph (DAG) of hypothesized relationships between patient characteristics and loss to follow-up (LTFU), with Period of First Attention (Pre/Post COVID-19) as the exposure.
حسب: Paulo Ruiz-Grosso (303702)
منشور في: (2025)

Spatial autocorrelation of TB LTFU in Ghana from 2019-2023.
حسب: David Ngmenbelle (21647429)
منشور في: (2025)

Hotspot analysis of TB LTFU among districts in Ghana from 2019-2023.
حسب: David Ngmenbelle (21647429)
منشور في: (2025)

Optimized analysis of TB LTFU among districts in Ghana from 2019-2023.
حسب: David Ngmenbelle (21647429)
منشور في: (2025)

Proportional distribution of TB LTFU among districts from 2019-2023.
حسب: David Ngmenbelle (21647429)
منشور في: (2025)

Map of Ghana with the 261 administrative districts.
حسب: David Ngmenbelle (21647429)
منشور في: (2025)

Outcomes of patients from restricted (Group 1) and non-restricted (Group 2) COVID-19 period with newly diagnosed nAMD of the first eye who have received aflibercept 2mg injections only.
حسب: Mike Y. Chen (13881956)
منشور في: (2025)

Standard Least Square Model of BCVA at different time points.
حسب: Mike Y. Chen (13881956)
منشور في: (2025)

Outcomes of patients from restricted (Group 1) and non-restricted (Group 2) COVID-19 period with newly diagnosed nAMD of the first eye.
حسب: Mike Y. Chen (13881956)
منشور في: (2025)

Baseline demographics and clinical characters of patients from restricted (Group 1) and non-restricted (Group 2) COVID-19 period with newly diagnosed nAMD of the first eye.
حسب: Mike Y. Chen (13881956)
منشور في: (2025)

Minimum data set.
حسب: Mike Y. Chen (13881956)
منشور في: (2025)

Bivariate and multivariate analysis.
حسب: Paulo Ruiz-Grosso (303702)
منشور في: (2025)

Survivor function for LTFU by type of admission, and period of initiation of care at INSM.
حسب: Paulo Ruiz-Grosso (303702)
منشور في: (2025)

Sample characteristics.
حسب: Paulo Ruiz-Grosso (303702)
منشور في: (2025)

OCT findings of epiretinal membrane (ERM), macular pseudohole (MPH), ERM-foveoschisis (ERM-FS) and lamellar macular hole (LMH).
حسب: Noriko Kubota (11915648)
منشور في: (2025)

Clinical characteristics of epiretinal membrane (ERM), macular pseudohole (MPH), ERM-foveoschisis (ERM-FS) and lamellar macular hole (LMH).
حسب: Noriko Kubota (11915648)
منشور في: (2025)

Relationships between preoperative OCT findings and visual acuity in epiretinal membrane (ERM), macular pseudohole (MPH), ERM-foveoschisis (ERM-FS) and lamellar macular hole (LMH).
حسب: Noriko Kubota (11915648)
منشور في: (2025)

Comparison of axial length (A) and spherical equivalent (B) in epiretinal membrane (ERM), macular pseudohole (MPH), ERM-foveoschisis (ERM-FS) and lamellar macular hole (LMH).
حسب: Noriko Kubota (11915648)
منشور في: (2025)

Comparison of central foveal thickness (CFT) (A), central retinal thickness (CRT) (B), and macular volume (MV) (C) in epiretinal membrane (ERM), macular pseudohole (MPH), ERM-foveoschisis (ERM-FS) and lamellar macular hole (LMH) Both the CFT and CRT were significantly higher in the ERM compared to the other three groups.
حسب: Noriko Kubota (11915648)
منشور في: (2025)

Multiple regression analysis between postoperative best-corrected visual acuity (BCVA) and preoperative BCVA and OCT findings in epiretinal membrane (ERM), macular pseudohole (MPH), ERM-foveoschisis (ERM-FS) and lamellar macular hole (LMH).
حسب: Noriko Kubota (11915648)
منشور في: (2025)

Best-corrected visual acuity (BCVA) before and after surgery in epiretinal membrane (ERM), macular pseudohole (MPH), ERM-foveoschisis (ERM-FS) and lamellar macular hole (LMH). a: Significantly different in the Wilcoxon’s signed-rank test. b: Significantly different in the Tukey-Kramer test.
حسب: Noriko Kubota (11915648)
منشور في: (2025)

Comparison of ERM areas and lengths between the two groups at the final follow-up.
حسب: Su Hwan Park (15158181)
منشور في: (2025)

Comparison of changes in ERM areas and lengths between the two groups at baseline and final follow-up.
حسب: Su Hwan Park (15158181)
منشور في: (2025)

Simple and multiple linear regression analyses between clinical factors and visual acuity change at final follow-up.
حسب: Su Hwan Park (15158181)
منشور في: (2025)

Changes in best-corrected visual acuity and total area reduction ratio of the epiretinal membrane (ERM) during follow-up.
حسب: Su Hwan Park (15158181)
منشور في: (2025)

Receiver operating characteristic curve for predicting 24-month vision loss using the total area reduction ratio at 6-month follow-up.
حسب: Su Hwan Park (15158181)
منشور في: (2025)

Cannot write session to /tmp/vufind_sessions/sess_4rddcj8tioqid8fdgl72f2jk3e